Vedanta plans to invest $500 million in group firm AvanStrate Inc.
The Hindu
Vedanta Limited invests $500 million in AvanStrate Inc. to drive innovation, expand R&D, and meet global demand for display glass.
Vedanta Limited has announced plans to invest close to $500 million in its group company, AvanStrate Inc. (ASI), which is a display glass manufacturer. Earlier this year, Vedanta acquired 98% stake in ASI.
“This investment is aimed at driving innovation and expansion within ASI, strengthening its focus on R&D, as well as manufacturing capabilities and product offerings to cater to global demand for advanced display glass solutions,” the company said in a statement.
Vedanta Group slapped with environmental fine of ₹71.16 crore for unauthorised dumping of fly ash in Odisha
“With operations and R&D capabilities in Taiwan, South Korea and Japan, ASI is planning to accelerate the development of next-generation glass products designed for advanced packaging and potential applications in the semiconductor, biotechnology, automotive displays, and other high-growth sectors,” Vedanta said.
“Additionally, ASI is exploring collaborative partnerships to accelerate its mission of developing technological advancement and enhanced market offerings,” it added.
Akarsh Hebbar, Global Managing Director, AvanStrate Inc., said, “This strategic investment from the Vedanta Group is reflective of our clear and definitive shift in focus toward significant growth-oriented projects.”
“We are confident that ASI’s cutting-edge R&D capabilities and world-class team of engineers are well placed to deliver a stream of future-ready solutions to our customers and partners propelling the company onto a path of positive industry disruption,” he added.
Equity markets decline on weak earnings, global trends; inflation hits 14-month high, foreign funds exit, oil prices rise.
Swiggy IPO debuts with a 7.69% jump at NSE, market valuation at ₹89,549.08 crore; shares listed at ₹412 on BSE.
Shares in Samsung Electronics fell on Wednesday to their lowest level in more than four years.
Mercedes-Benz India introduces the new Mercedes-AMG C 63 S E Performance sportscar with hybrid powertrain and innovative business model.
Hyundai Motor India Ltd. reports 16% profit decline in Q3 due to market sentiments, geopolitical factors, and Red Sea crisis.
Equity market plunges over 800 points, eroding market capitalisation by ₹5.29 lakh crore amid global economic concerns.
Aurobindo Pharma's CuraTeQ Biologics receives EMA GMP certificate for biosimilars, paving way for European approvals of three products.
BCCI to withdraw insolvency plea against Byju's after Supreme Court sets aside NCLAT judgement, NCLT hearing scheduled.
Natco Pharma's Q2 profits soar 83% to ₹676.5 crore, driven by robust exports and stable domestic business.
India's industrial output rebounds with 3.1% growth in September, led by manufacturing, despite weak electricity and mining sectors.
India's retail inflation hits 6.2% in October, driven by a 10.9% spike in food prices, breaching RBI's upper limit.